Phthalocyanine-biopolymeric nanoparticle delivery systems for cancer photodynamic therapy

Project description

Nanoparticles for the delivery of photodynamic therapy agents

Photodynamic therapy (PDT) is a minimally invasive treatment that combines photosensitising drugs, oxygen and light to kill cancer cells. It is a selective approach with minimal side effects on normal tissues, offering a promising alternative to standard chemotherapy. Despite its approval for clinical use 20 years ago, PDT still finds limited use in most cancer types. The EU-funded BIOnanoPDT project proposes to incorporate phthalocyanine as the photosensitising drug into functionalised biodegradable polymeric nanoparticles to target tumour cells. This will help to address issues associated with the selectivity, aggregation and low water solubility of photosensitising drugs, enhancing the application of PDT in the clinic.

Fields of science

• natural sciences › chemical sciences › polymer sciences
• medical and health sciences › clinical medicine › oncology
• engineering and technology › nanotechnology › nano-materials

Programme(s)

• H2020-EU.4. - SPREADING EXCELLENCE AND WIDENING PARTICIPATION Main Programme

Topic(s)

• WF-02-2019 - Widening Fellowships

Call for proposal

H2020-WF-2018-2020

See other projects for this call

Sub call

H2020-WF-02-2019

Funding Scheme

MSCA-IF-EF-ST - Standard EF

Coordinator

CENTRUM MATERIALOW POLIMEROWYCH IWEGLOWYCH POLSKA AKADEMIA NAUK*CMPIW PAN

Net EU contribution

€ 149 625,60

Address

Ul. M Curie Sklodowskiej 34
41 819 Zabrze
Poland

Region

Makroregion południowy › Śląskie › Gliwicki

Activity type

Research Organisations

Links

Other funding

€ 0,00